Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis.

Atsushi SakurabaAlexander LunaDejan Micic

Published in: Journal of hematology & oncology (2022)

Patients with cancer, especially those with hematologic B-cell malignancies, have a lower serologic response to COVID-19 vaccines. The results suggest that cancer patients should continue to follow safety measures including mask-wearing after vaccination and suggest the need for additional strategies for prophylaxis.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
sleep apnea